Mark Avagliano
Overview
Mark Avagliano received an average of $2M in total compensation, including $381K in salary, at G1 Therapeutics from 2019 to 2022.
Source: SEC filings on April 26, 2023, April 28, 2021, and April 24, 2020.
Related executives
We found nine more executives who work or worked at G1 Therapeutics.
John Bailey
G1 Therapeutics
Chief Executive Officer
Jennifer Moses
G1 Therapeutics
Chief Financial Officer
Mark Velleca
G1 Therapeutics
Chief Executive Officer
Soma Gupta
G1 Therapeutics
Chief Commercial Officer
Rajesh Malik
G1 Therapeutics
Chief Medical Officer
John Demaree
G1 Therapeutics
Chief Commercial Officer
Barclay Phillips
G1 Therapeutics
Chief Financial Officer
James Hanson
G1 Therapeutics